CHICAGO — Major League Soccer team Chicago Fire announced Wednesday that the club has acquired striker David Arshakyan from Lithuanian A Lyga side FK Trakai. The Armenian international signed a two-year deal with club options for the third and fourth years, and will be added to the Fire roster upon receipt of his ITC and P1 Visa.

“As we tracked David, we were impressed by his winning attitude and ability to score goals in a variety of different ways,” said Fire general manager Nelson Rodriguez. “He has a very good soccer IQ, imagination and obvious size. David also expressed a keen desire to join our club in particular and to help us build a championship program.”

Arshakyan began his professional career with Armenian side FC Mika in 2012 and made three Premier League appearances as his side captured the 2012-13 Armenian Super Cup.

This season, Arshakyan has scored nine goals in 18 appearances, including a hat trick in a 4-3 win over Utenis Utena on July 28.

Arshakyan additionally appeared in six UEFA Europa League qualifiers for Trakai, scoring five total goals including a brace against Havnar Boltfelag on July 9, 2015.

Arshakyan made his international debut for Armenia on March 29, 2016, earning the start against Denmark in the UEFA U21 Championship qualifying match.

David Arshakyan is born August 16, 1994 in Saint Petersburg, Russia.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletters

Get notified of the latest updates from MassisPost.

You May Also Like

Camp Armen to Be Rebuilt

PARAMUS, NJ – The Armenian Missionary Association of America (AMAA) welcomes the…

Switzerland Appeals ECHR Ruling

BERN, SWITZERLAND — The Swiss Government announced today it will appeal the…

Former Istanbul Police Chief Summoned to Testify in Dink Murder Trial

ISTANBUL — Former Istanbul Police Chief Celalettin Cerrah has been summoned to…

Director of Eastern Diocese’s Zohrab Center Presents New Research to American Anthropological Assoc.

NEW YORK — On Friday, November 16, Dr. Christopher Sheklian, director of…